Diagnostic and surgical approaches to treating the disease are evolving — just as rates are spiking. Learn how the surgical ...
A new study published in the journal of BMC Surgery showed that in a group of chosen patients with sudden blockage in the ...
In pMMR/MSS colon cancer, neoadjuvant BOT+BAL met the trial’s primary endpoint with a 36% major pathologic response rate, including 29% pathologic complete response, within an overall 71% pathologic ...
UNICORN Challenges Immunotherapy Resistance in MSS Colon Cancer / Agenus, Balstilimab, botensilimab, cancer, Colon cancer, colorectal cancer, ctDNA, Filippo ...
If it might be cancer, please take a sample and clarify it quickly.This is a phrase I often hear from patients and their families when pancreatic cancer is suspected.It is very natural to feel that ...
Hosted on MSN
My tiredness and back pain were dismissed as gallstones - in fact it was a little-known cancer
Tania Sparkes, 40, from Greater Manchester tells her story. My symptoms started in my late twenties, around 2015, when I suddenly became completely exhausted. I just put it down to everyday life, ...
What she thought was the flu turned out to be a medical emergency.
This time, instead of talking about my children's studies, I'm sharing the story of how I (a mom in my late 40s) had my first ...
Basel, 9 October 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Tecentriq® (atezolizumab) and Tecentriq Hybreza® (atezolizumab ...
A new Cell Division study reports that linalool stabilizes the NR3C2 protein in gastric cancer cells, activating NFKBIZ and ...
A retrospective Chinese cohort study of 308 older colorectal cancer patients found that 55.52% carried preoperative frailty ...
Colorectal Cancer Trials to Watch at ESMO 2026 / cancer, cancer care, Cancer research, cancer treatment, chemotherapy, clinical trials, colorectal cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results